Schneider Hp

No ORCID on file · 11 papers in corpus · active 1981-1995

Study types

  • article 9
  • case-report 2

Condition tags

  • endometriosis 11
  • dysmenorrhea 1
  • chronic_pelvic_pain 1
  • mesh:D004716 1
  • dyspareunia 1
article 1995
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/0028-2243(94)02016-8

To compare treatment efficacy and safety parameters a total of 55 premenopausal women with histologically proven endometriosis (stage II-IV) were randomized to receive the LHRH-analogue depot triptorelin (n = 30) or the steroid danazol (n =…

article 1993
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/0028-2243(93)90052-e

A panel of monoclonal antibodies specific for macrophage subtypes appearing in early (27E10), down-regulatory (RM3/1) and late (25F9) stages of inflammation had been applied to 20 endometriotic implants of 14 women. Of those patients 9 were…

article 1991
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2007-1026212

CA 125, CA 19-9, CA 15-3 and CEA were measured in 42 patients with histologically verified endometriosis, who had been treated for six months by the LHRH-analogue buserelin (900 mcg/d intranasally). Before therapy, for all of the markers te…

article 1990
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2007-1026452

LHRH analogue therapy has proved effective in the treatment of endometriosis. Although in the majority of patients a marked reduction in AFS implant score is observed, in some cases residual endometriotic foci are macroscopically suspected …

article 1989
Archives of gynecology and obstetrics ·doi:10.1007/bf00934075

To investigate the effects of the LH-RH agonist Buserelin [D-Ser (But)6 des-Gly10-LHRH ethylamide] on endometriosis, 64 patients were treated with 900 micrograms/d Buserelin intranasally over 6 months after histological verification of the …

article 1987
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2008-1035798

Between 1983 and 1986 40 patients were treated for external genital endometriosis with the LHRH agonist buserelin. Ovarian suppression was achieved for a period of six months with a dose of 900 to 1,800 mcg per day. In addition to gynecolog…

case-report 1986
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2008-1035981

Careful and early surgical intervention allowed preservation of the uterus following ruptured interstitial pregnancies in two women still desirous of pregnancy. One patient had a history of extirpation of the ipsilateral adnexa, the other p…

article 1986
Progress in clinical and biological research
article 1986
Progress in clinical and biological research
case-report 1986
Ultraschall in der Medizin (Stuttgart, Germany : 1980) ·doi:10.1055/s-2007-1011941

The authors present a case of an interstitial extrauterine pregnancy in the intramural portion of the left oviduct after preceding ipsilateral adnectomy. Sonographic diagnosis was confirmed by the site at operation.

article 1981
Fertility and Sterility ·doi:10.1016/s0015-0282(16)45915-7

Patients (n = 10) with endometriosis or fibrocystic mammary disease were treated with an oral dose of 4 x 200 mg danazol for 6 months. Prolactin and gonadotropin secretion was evaluated before, and in some of them during 1, 3, and 6 months …